Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain

Synapse

Volumn 36, Issue 3, 2000, Pages 167-177

  Eastwood, Sharon L ^a,b   Burnet, Philip W J ^a   Harrison, Paul J ^a,b  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Complexins; Gene expression; In situ hybridization; Neuroleptic; Synaptophysin

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SYNAPTOPHYSIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; FOREBRAIN; GENE EXPRESSION REGULATION; GENE LOCATION; HABENULA; HIPPOCAMPUS; NONHUMAN; OLFACTORY CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; THALAMUS;

ANIMALS; ANTIPSYCHOTIC AGENTS; MALE; NERVE TISSUE PROTEINS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SYNAPTOPHYSIN; TISSUE DISTRIBUTION;

EID: 0034213344     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(20000601)36:3<167::AID-SYN2>3.0.CO;2-D     Document Type: Article

References (56)

1. Amaral DG, Witter M. 1995. Hippocampal formation. In: Paxinos G, editor. The rat nervous system, 2nd ed. San Diego: Academic Press. p 443-493.
2. Arnt J, Skarsfeldt T. 1998. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropharmacology 18:63-101.
3. Benes FM, Paskevich P, Davidson J, Domesick VB. 1985. The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res 329:265-274.
4. Bolam JP, Powell JF, Wu JY, Smith AD. 1985. Glutamate decarboxylase-immunoreactive structures in the rat neostriatum: a correlated light and electron microscopic study including a combination of Golgi impregnation with immunocytochemistry. J Comp Neurol 237:1-20.
5. Boschert U, O'Shaughnessy C, Dickinson R, Tessari M, Bendotti C, Catsicas S. 1996. Developmental and plasticity-related differential expression of two SNAP-25 isoforms in the rat brain. J Comp Neurol 367:177-193.
6. Butcher LL. 1995. Cholinergic neurons and networks. In: Paxinos G, editor. The rat nervous system, 2nd ed. San Diego: Academic Press. p 1003-1016.
7. Celio M. 1990. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35:375-475.
8. DeFelipe J. 1997. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat 14:1-19.
9. Eastwood SL, Burnet PWJ, Harrison PJ. 1994. Striatal synaptophysin expression and haloperidol-induced synaptic plasticity. Neuroreport 5:677-680.
10. Eastwood SL, Burnet PWJ, Harrison PJ. 1995. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 66:309-319.
11. Eastwood SL, Porter RHP, Harrison PJ. 1996. The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain. Neurosci Lett 212:163-166.
12. Eastwood SL, Heffernan J, Harrison PJ. 1997. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes. Mol Psychiatry 2:322-329.
13. Furuyashiki T, Fujisawa K, Fujita A, Maduale P, Uchino S, Mishina M, Bito H, Narumiya S. 1999. Citron, a rho-target, interacts with PSD-95/SAP-90 at glutamatergic synapses in the thalamus. J Neurosci 19:109-118.
14. Garner CC, Tucker RP, Matus A. 1988. Selective localization of messenger RNA for cytoskeletal protein MAP2 in dendrites. Nature 336:674-677.
15. Harrison PJ. 1999. The neuropathological effects of antipsychotic drugs. Schizophr Res 40:87-99.
16. Harrison PJ, Eastwood SL. 1998. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 352:1669-1673.
17. Ishizuka T, Saisu H, Odani S, Abe T. 1995. Synaphin: a protein associated with the docking/fusion complex in presynaptic terminals. Biochem Biophys Res Commun 213:1107-1114.
18. Ishizuka T, Saisu H, Odani S, Kumanishi T, Abe T. 1999. Distinct regional distribution in the brain of messenger RNAs for the two isoforms of synaphin associated with the docking/fusion complex. Neuroscience 88:295-306.
19. Kadowaki K, McGowan E, Mock G, Chandler S, Emson PC. 1993. Distribution of calcium binding protein mRNAs in rat cerebellar cortex. Neurosci Lett 153:80-84.
20. Katsumaru H, Kosaka T, Heizmann C, Hama K. 1988. Immunocytochemical study of GABAergic neurons containing the calcium-binding protein parvalbumin in the rat hippocampus. Exp Brain Res 72:347-362.
21. Kerns JM, Sierens DK, Kao LC, Klawans HL, Carvey PM. 1992. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuorpharmacol 15:488-500.
22. Kinon BJ, Lieberman JA. 1996. Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology 124: 2-34.
23. Kita H, Kitai ST. 1988. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res 447:346-352.
24. Kleiman R, Banker G, Steward O. 1990. Differential subcellular localization of particular mRNAs in hippocampal neurons in culture. Neuron 5:821-830.
25. Kroesen S, Marksteiner J, Mahata SK, Mahata M, Fischer-Colbrie R, Saria A, Kapeller I, Winkler H. 1995. Effects of haloperidol, clozapine and citalopram on messenger RNA levels of chromogranins A and B and secretogranin II in various regions of rat brain. Neuroscience 69:881-891.
26. Kuhl D, Skehel P. 1998. Dendritic localization of mRNAs. Curr Opin Neurobiol 8:600-606.
27. Lin JW, Sheng M. 1998. NSF and AMPA receptors get physical. Neuron 21:267-270.
28. Maletic-Savatic M, Malinow R. 1998. Calcium-evoked dendritic exocytosis in cultured hippocampal neurons. I. Trans-Golgi network-derived organelles undergo regulated exocytosis. J Neurosci 18: 6803-6813.
29. Marin C, Tolosa E. 1997. Striatal synaptophysin levels are not indicative of dopaminergic supersensitivity. Neuropharmacology 36:1115-1117.
30. Marquèze-Pouey B, Wisden W, Malosio ML, Betz H. 1991. Differential expression of synaptophysin and synaptoporin mRNAs in the post-natal rat central nervous system. J Neurosci 11:3388-3397.
31. Matus-Leibovitch N, Nevo I, Vogel Z. 1997. Differential distribution of synapsin IIa and IIb mRNAs in various brain structures and the effect of chronic morphine administration on the regional expression of these isoforms. Mol Brain Res 45:301-316.
32. McMahon HT, Missler M, Li C, Südhof TC. 1995. Complexins: cytosolic proteins that regulate SNAP receptor function. Cell 83:111-119.
33. Meshul CK, Casey DE. 1989. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res 489:338-346.
34. Meshul CK, Janowsky A, Casey DE, Stallbaumer RK, Taylor B 1991. Effect of haloperidol and clozapine on the density of 'perforated' synapses in caudate, nucleus accumhens, and medial prefrontal cortex. Psychopharmacology 106:45-52.
35. Meshul CK, Bunker GL, Mason JN, Allen C, Janowsky A. 1996. Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses, J Neurochem 67:1965-1973.
36. Morris PJ, Lakin ND, Dawson SJ, Ryabinin AE, Kilimann MW, Wilson MC, Latchman DS. 1996. Differential regulation of genes encoding synaptic proteins by members of the Brn-3 subfamily of POU transcription factors. Mol Brain Res 43:279-285.
37. Nakahara T, Nakamura K, Tsutsumi T, Hashimoto K, Hondo H, Hisatoni S, Motomura K, Uchimura H. 1998. Effect of chronic haloperidol treatment on synaptic protein mRNAs in the rat brain. Mol Brain Res 61:238-242.
38. Ni B, Du Y, Wu X, DeHoff BS, Rosteck PR Jr, Paul SM. 1996. Molecular cloning, expression, and chromosomal localisation of a human brain-specific Na+-dependent inorganic phosphate cotransporter. J Neurochem 66:2227-2238.
39. Ono S, Baux G, Sekiguchi M, Fossier P, Morel NF, Nihonmatsu I, Hirata K, Awaji T, Takahashi S, Takahashi M. 1998. Regulatory roles of complexins in neurotransmitter release from mature presynaptic nerve terminals. Eur J Neurosci 10:2143-2152.
40. Peters A, Palay SL. 1996. The morphology of synapses. J Neurocytol 25:687-700.
41. Plunkett JA, Baccus SA, Bixby JL. 1998. Differential regulation of synaptic vesicle protein genes by target and synaptic activity. J Neurosci 18:5832-5838.
42. Roberts RC, Gaither LA, Gao X-M, Kashyap SM, Tamminga CA. 1995. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum. Synapse 20:234-243.
43. Rodriguez RM, Weickert CS, Herman MM, Hyde TM, Webster MJ, Weinberger DR, Kleinman JE. 1998. Synaptophysin mRNA in normal postnatal prefrontal cortex development and in schizophrenic versus normal control. Soc Neurosci Abstr 24:987.
44. Sloviter RS. 1989. Calcium-binding protein (calbindin-D-28k) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J Comp Neurol 280:183-212.
45. Söllner T, Rothman JE. 1994. Neurotransmission: harnessing fusion machinery at the synapse. Trends Neurosci 17:344-348.
46. Steward O, Banker GA. 1992. Getting the message from the gene to the synapse. Sorting and intracellular transport of RNA in neurons. Trends Neurosci 15:180-186.
47. Südhof T. 1995. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature 375:645-653.
48. Takahashi S, Yamamoto H, Matsuda Z, Ogawa M, Yagyu K, Taniguchi T, et al. 1995. Identification of two highly homologous presynaptic proteins distinctly localised at the dendritic and somatic synapses. FEBS Lett 368:455-460.
49. Takahashi S, Ujihara H, Huang GZ, Yagyu K, Sanbo M, Kaba H, Yagi T. 1999. Reduced hippocampal LTP in mice lacking a presynaptic protein, complexin II. Eur J Neurosci 11:2359-2366.
50. Tcherepanov AA, Sokolov BP. 1997. Age-related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics. J Neurosci Res 49:639-644.
51. Uranova NA, Orlovskaya D, Apel K, Klintsova A, Haselhorst U, Schenk H. 1991. Morphometric study of synaptic patterns in the rat caudate nucleus and hippocampus under haloperidol treatment. Synapse 7:253-259.
52. Vincent SL, McSparren J, Wang RY, Benes FM. 1991. Evidence for ultrastructural changes in cortical axodendritic synapses following long-term treatment with haloperidol or clozapine. Neuropsychopharmacology 5:147-155.
53. Woodman PG. 1997. The roles of NSF, SNAPs and SNAREs during membrane fusion. Biochem Biophys Acta 1357:155-172.
54. Wuenschell CW, Fisher RS, Kaufman DL, Tobin AJ. 1986. In situ hybridization to localize mRNA encoding the neurotransmitter synthetic enzyme glutamate decarboxylase in mouse cerebellum. Proc Natl Acad Sci USA 83:6193-6197.
55. Yamada M, Saisu H, Ishizuka T, Takahashi H, Abe T. 1999. Immunohistochemical distribution of the two isoforms of synaphin/complexin involved in neurotransmitter release: localization at the distinct central nervous system regions and synaptic types. Neuroscience 93:7-18.
56. Zhang W, Vazquez L, Apperson M, Kennedy MB. 1999. Citron binds to PSD-95 at glutamatergic synapses on inhibitory neurons in the hippocampus. J Neurosci 19:96-108.